Edward Balmond
About Edward Balmond
Edward Balmond is a Senior Scientist at BenevolentAI in Cambridge, United Kingdom, with a strong research background in the pharmaceuticals industry and expertise in UV/Vis Spectroscopy, Carbohydrate Chemistry, NMR Spectroscopy, and Organic Synthesis.
Title and Current Role
Edward Balmond holds the position of Senior Scientist at BenevolentAI, a role he has occupied since April 2018. He works in Cambridge, United Kingdom, where he contributes to cutting-edge research in the pharmaceutical industry.
Educational Background
Edward Balmond completed his education at the University of Bristol, where he earned a Doctor of Philosophy (PhD) in Organic Chemistry from 2009 to 2014. Prior to his doctoral studies, he obtained a Master of Science (MSc) in Chemistry from the same institution, studying from 2005 to 2009.
Industry Expertise
Edward Balmond has expertise in several key areas of chemistry and pharmaceuticals, including UV/Vis Spectroscopy, Carbohydrate Chemistry, NMR Spectroscopy, and Organic Synthesis. He has a strong research background that spans various positions in the pharmaceutical industry.
Professional Experience
Edward Balmond's career includes several notable positions. He worked as a Senior Scientist at Proximagen Limited from 2016 to 2018 in Cambridge, United Kingdom. He was a Postdoctoral Researcher at UC Davis in Davis, CA from 2014 to 2016. Additionally, he completed a PhD CASE Placement at GSK in Stevenage, United Kingdom in 2012, and served as an Analytical Chemist at AstraZeneca in Avlon, Bristol for 11 months from 2007 to 2008.
SCI Young Chemists Panel Member
From 2017 to 2020, Edward Balmond was a Young Chemists Panel Member at SCI: Where Science Meets Business. During his three-year tenure, he contributed to the organization's mission to bridge the gap between science and business.